Clinical Trials Directory

Trials / Conditions / Mucormycosis

Mucormycosis

18 registered clinical trials studyying Mucormycosis — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project
NCT06878144
M.D. Anderson Cancer Center—
Not Yet RecruitingIsavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359
Shanghai 10th People's Hospital—
Active Not RecruitingAmphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
NCT07191756
Qiu Ye—
CompletedDisease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single
NCT06900114
Institute of Hematology & Blood Diseases Hospital, China—
RecruitingStudy on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children
NCT06440915
Shanghai Children's Medical CenterN/A
Active Not RecruitingRehabilitation With an Obturator in Maxillary Defects
NCT06515743
Menoufia University—
RecruitingBiomarkers for Invasive Mucormycosis
NCT05406037
University Hospital, Lille—
UnknownMucorales PCR Screening in At-risk Hematology Patients
NCT05925660
Universitaire Ziekenhuizen KU LeuvenN/A
CompletedCOVID-19 and Rhino-orbital Mucormycosis
NCT05212961
Minia University—
CompletedPost Marketing Surveillance (PMS) Study of Cresemba in Korea.
NCT04744454
Pfizer—
UnknownOcular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
NCT05097664
Isfahan University of Medical Sciences—
CompletedMucormycosis in COVID-19
NCT04935463
Montefiore Medical Center—
CompletedA Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditio
NCT04550936
Pfizer—
CompletedCOVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
NCT05074043
Assiut University—
CompletedEvaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
NCT05348434
Tishreen University—
CompletedMucormycosis in ICU
NCT03387696
University Hospital, Grenoble—
CompletedProspective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
NCT02845934
Centre Hospitalier Universitaire de BesanconN/A
CompletedThe Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
NCT00419770
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterPhase 2